| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Gertrude H. Sergievsky Center (Dr. Albert), the Department of Neurology (Dr. Albert, P.L. Murphy, M.L. Del Bene, and Dr. Rowland), and Eleanor and Lou Gehrig MDA/ALS Center (P.L. Murphy, M.L. Del Bene, and Dr. Rowland), Columbia University; and Department of Biopsychology (P.L. Murphy), Hunter College, Graduate Center City University of New York, NY.
Address correspondence and reprint requests to Dr. Steven M. Albert, Gertrude H. Sergievsky Center, P & S Box 16, Columbia University, 630 West 168th St., New York, NY 10032; e-mail: sma10{at}columbia.edu
OBJECTIVE: To determine whether ALS patients’ preferences for ameliorative or life-extending technologies elicited early in the disease were related to later treatment choices.
METHODS: In this prospective cohort study, 121 patients were seen at a tertiary ALS care center and followed for a median of 12 months. At baseline, patient preferences for use of tracheostomy and percutaneous endoscopic gastrostomy (PEG) placement were elicited. All patients received the same educational information before being interviewed about treatment preferences. Patients were then followed to determine if patients who viewed the interventions favorably at baseline were significantly more likely to use the interventions over follow-up.
RESULTS: Six to twelve percent of patients were certain they wanted tracheostomy and 28.2% wanted PEG. Preferences were related to later treatment choices: 20% of patients who found tracheostomy acceptable had one in the follow-up period, compared with 3.4% of those not in favor (p < 0.001). For PEG, similar findings were obtained: 48.5% who initially found it acceptable had PEG, versus 8.1% of those not in favor of this treatment (p < 0.001). Patients who found the interventions acceptable were more likely to be recently diagnosed, expressed greater attachment to life, and showed greater declines in pulmonary function over follow-up.
CONCLUSIONS: Patients with ALS were able to express their preferences for life-extending or ameliorative technologies and made choices consistent with these preferences. However, patient preferences may change over time, and clinical education efforts are required throughout the course of disease.
This article has been cited by other articles:
|
|
 |
|
  H. Mitsumoto and J. G. Rabkin Palliative Care for Patients With Amyotrophic Lateral Sclerosis: "Prepare for the Worst and Hope for the Best" JAMA, July 11, 2007; 298(2): 207 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Elman, L. Stanley, P. Gibbons, and L. McCluskey A cost comparison of hospice care in amyotrophic lateral sclerosis and lung cancer. American Journal of Hospice and Palliative Medicine, May 1, 2006; 23(3): 212 - 216. [Abstract] [PDF]
|
|
|
|
|
|
S. H. Appel Euthanasia and physician-assisted suicide in ALS: A commentary American Journal of Hospice and Palliative Medicine, November 1, 2004; 21(6): 405 - 406. [PDF]
|
|
|
|
 |
|
 M. Dobratz A Comparative Study of Variables That Have an Impact on Noncancer End-of-Life Diagnoses Clin Nurs Res, November 1, 2004; 13(4): 309 - 325. [Abstract] [PDF]
|
|
|
|
 |
|
 R S Howard and R W Orrell Management of motor neurone disease Postgrad. Med. J., December 1, 2002; 78(926): 736 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chio, G. Mora, M. Leone, L. Mazzini, D. Cocito, M. T. Giordana, E. Bottacchi, and R. Mutani Early symptom progression rate is related to ALS outcome: A prospective population-based study Neurology, July 9, 2002; 59(1): 99 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M D Bradley, R W Orrell, J Clarke, A C Davidson, A J Williams, D M Kullmann, N Hirsch, and R S Howard Outcome of ventilatory support for acute respiratory failure in motor neurone disease J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 752 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Bradley, F. Anderson, M. Bromberg, L. Gutmann, Y. Harati, M. Ross, and R. G. Miller Current management of ALS: Comparison of the ALS CARE Database and the AAN Practice Parameter Neurology, August 14, 2001; 57(3): 500 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Rowland and N. A. Shneider Amyotrophic Lateral Sclerosis N. Engl. J. Med., May 31, 2001; 344(22): 1688 - 1700. [Full Text] [PDF]
|
|
|
|
|
|
N. Lechtzin, C. M. Wiener, L. Clawson, V. Chaudhry, and G. B. Diette Hospitalization in amyotrophic lateral sclerosis: Causes, costs, and outcomes Neurology, March 27, 2001; 56(6): 753 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Brett and J. C. Rosenberg The Adequacy of Informed Consent for Placement of Gastrostomy Tubes Arch Intern Med, March 12, 2001; 161(5): 745 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Rumbak and R. M. Walker Should Patients With Neuromuscular Disease Be Denied the Choice of the Treatment of Mechanical Ventilation? Chest, March 1, 2001; 119(3): 683 - 684. [Full Text] [PDF]
|
|
|
|
|
|
P. L. Murphy, S. M. Albert, C. M. Weber, M. L. Del Bene, and L. P. Rowland Impact of spirituality and religiousness on outcomes in patients with ALS Neurology, November 28, 2000; 55(10): 1581 - 1584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mitsumoto Patient choices in ALS Neurology, July 1, 1999; 53(2): 248 - 248. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
